Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
12/2016 not set
Endobetix
Endobetix Overview
Endobetix is developing a minimally invasive, nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery. Implanted endoscopically, the Endobetix Bile Diversion Device (BDD) reroutes bile and pancreatic secretions from the duodenum to the lower part of the small intestine. This diversion changes the hormonal balance and induces the release of key hormones such as GLP-1 to improve glucose tolerance and reduce fat absorption. The BDD can be implanted by gastroenterologists and bariatric surgeons in an outpatient procedure.